Literature DB >> 2470908

Protective effect of a prostacyclin-mimetic on the ischaemic-reperfused rabbit myocardium.

R Ferrari1, A Cargnoni, C Ceconi, S Curello, S Belloli, A Albertini, O Visioli.   

Abstract

To assess whether the administration of the stable prostacyclin-mimetic ZK 36374 (iloprost) protects the myocardium in a dose-dependent manner against ischaemia and reperfusion, isolated rabbit hearts were infused with three different concentrations of iloprost: 2.7, 27 and 270 nM. Diastolic and developed pressures were monitored; coronary effluent was collected and assayed for creatine phosphokinase (CPK) activity and for noradrenaline concentration; mitochondria were harvested and assayed for respiratory activity; ATP production and calcium content and tissue concentration of adenosine triphosphate (ATP) and creatine phosphate (CP) were determined. Treatment with iloprost altered neither developed pressure under normoxic conditions nor the rate and extent of depletion of ATP and CP during ischaemia. The ischaemic-induced deterioration of mitochondrial function, however, was attenuated. On reperfusion, hearts treated with iloprost recovered better than the untreated hearts with respect to left ventricular performance, replenishment of ATP and CP stores and mitochondrial function. The reperfusion-induced mitochondrial calcium overload and release of CPK and of noradrenaline were also significantly reduced. The effect of iloprost was dose-dependent. The lower concentration (2.7 nM) failed to modify ischaemic and reperfusion damage. The best protective effect was found at 27 nM. An increase of the dose to 270 nM did not result in further protection. It is concluded that iloprost infusion provides a dose-dependent protection of the heart against some of the deleterious effects of ischaemia and reperfusion and, in particular, prevents mitochondrial calcium overload and maintains mitochondrial function. Because this protection occurred in the absence of negative inotropic effect during normoxia or of a coronary dilatory effect during ischaemia, it cannot be attributed to an energy sparing effect or to improvement of oxygen delivery. Therefore, alternative mechanisms of action are to be considered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2470908     DOI: 10.1016/0022-2828(88)90590-1

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

Review 1.  Advances in thrombolytic therapy.

Authors:  M Verstraete
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

2.  Beneficial effect of beraprost, a prostacyclin-mimetic agent, on post-hypoxic recovery of cardiac function and metabolism in rabbit isolated hearts.

Authors:  K Tanonaka; Y Maruyama; S Takeo
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Prostaglandins and the antiarrhythmic effect of preconditioning in the isolated rat heart.

Authors:  M Arad; T Oxman; R Leor; B Rabinowitz
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

4.  Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts.

Authors:  R Ferrari; A Cargnoni; S Curello; G M Boffa; C Ceconi
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  Role of timing of administration in the cardioprotective effect of fructose-1,6-bisphosphate.

Authors:  A Cargnoni; E Condorelli; A Boraso; L Comini; F De Giuli; E Pasini; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 6.  Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Authors:  S M Grant; K L Goa
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

7.  The effect of iloprost and N-acetylcysteine on skeletal muscle injury in an acute aortic ischemia-reperfusion model: an experimental study.

Authors:  Osman Tiryakioglu; Kamuran Erkoc; Bulent Tunerir; Onur Uysal; H Firat Altin; Tevfik Gunes; Selim Aydin
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

8.  Nitroglycerin and Iloprost Improve Mitochondrial Function in Colon Homogenate Without Altering the Barrier Integrity of Caco-2 Monolayers.

Authors:  Anna Herminghaus; Rebecca Eberhardt; Richard Truse; Jan Schulz; Inge Bauer; Olaf Picker; Christian Vollmer
Journal:  Front Med (Lausanne)       Date:  2018-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.